FENC
Fennec Pharmaceuticals (FENC)
$60
About Fennec Pharmaceuticals (FENC)
Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.
Details
Daily high
$4.60
Daily low
$4.50
Price at open
$4.53
52 Week High
$11.92
52 Week Low
$4.50
Market cap
125.0M
Dividend yield
0.00%
Volume
25,210
Avg. volume
89,793
P/E ratio
116.28
Fennec Pharmaceuticals News
Details
Daily high
$4.60
Daily low
$4.50
Price at open
$4.53
52 Week High
$11.92
52 Week Low
$4.50
Market cap
125.0M
Dividend yield
0.00%
Volume
25,210
Avg. volume
89,793
P/E ratio
116.28